Literature DB >> 20421622

Poloxamer 188 inhibition of ischemia/reperfusion injury: evidence for a novel anti-adhesive mechanism.

Robert L Hunter1, Annie Z Luo, Rongzhen Zhang, Rosemary A Kozar, Frederick A Moore.   

Abstract

Poloxamer 188 (P188) is a nonionic block copolymer surfactant that has rheologic, anti-thrombotic, anti-inflammatory, and cytoprotective activities. Several mechanisms have previously been proposed, but none explain all of the observed effects. In this study, superior mesenteric artery occlusion (SMAO) was employed as a clinically relevant model of ischemia/reperfusion. The superior mesenteric artery of rats was clamped for one hr and and followed by reperfusion with P188 or saline for five hr, after which tissues were harvested for expression microarray, histologic, enzymatic, and western blot analyses. The results demonstrated that P188 significantly inhibits the entire spectrum of inflammatory, coagulation, and apoptotic responses produced by SMAO. This supports the existence of a novel mechanism that recognizes two types of adhesive interactions. The first, specific receptor-ligand adhesion, governs interactions between cells and molecules and is unaffected by P188. P188 affects only the second type, hydrophobic adhesion, which is responsible for the integrity of membranes and conformation of proteins. Hydrophobic interactions are non-specific because they derive from repulsion of water rather than from affinity of molecules for one another. Ischemic membranes develop defects that expose underlying hydrophobic structures and trigger multiple deleterious responses. Fat emboli and hydrophobic proteins such as fibrin produced by the injury further compromise the microcirculation. The unique structure of P188 facilitates its rapid, but gentle, binding to any exposed hydrophobic domain, restoring normal non-adhesive surfaces and thereby preventing activation of the entire spectrum of deleterious reactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421622

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  10 in total

Review 1.  Novel pharmacotherapy for burn wounds: what are the advancements.

Authors:  Michael R Hamblin
Journal:  Expert Opin Pharmacother       Date:  2018-12-05       Impact factor: 3.889

2.  The purified vepoloxamer prevents haemolysis in 42-day stored, DEHP/PVC-free red blood cell units.

Authors:  Jose A Cancelas; Neeta Rugg; Shawnagay Nestheide; Sarah E Hill; R Martin Emanuele; Douglas S Mckenzie
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

3.  The role of NIGMS P50 sponsored team science in our understanding of multiple organ failure.

Authors:  Frederick A Moore; Ernest E Moore; Timothy R Billiar; Yoram Vodovotz; Anirban Banerjee; Lyle L Moldawer
Journal:  J Trauma Acute Care Surg       Date:  2017-09       Impact factor: 3.313

4.  Surface Plasmon Resonance Study of the Binding of PEO-PPO-PEO Triblock Copolymer and PEO Homopolymer to Supported Lipid Bilayers.

Authors:  Mihee Kim; Milan Vala; Christopher T Ertsgaard; Sang-Hyun Oh; Timothy P Lodge; Frank S Bates; Benjamin J Hackel
Journal:  Langmuir       Date:  2018-06-01       Impact factor: 3.882

5.  Poloxamer-188 attenuates TBI-induced blood-brain barrier damage leading to decreased brain edema and reduced cellular death.

Authors:  Hai-Jun Bao; Tao Wang; Ming-Yang Zhang; Ran Liu; Ding-Kun Dai; Yao-Qi Wang; Long Wang; Lu Zhang; Yu-Zhen Gao; Zheng-Hong Qin; Xi-Ping Chen; Lu-Yang Tao
Journal:  Neurochem Res       Date:  2012-09-26       Impact factor: 3.996

6.  Degradable and Removable Tough Adhesive Hydrogels.

Authors:  Benjamin R Freedman; Oktay Uzun; Nadja M Maldonado Luna; Anna Rock; Charles Clifford; Emily Stoler; Gabrielle Östlund-Sholars; Christopher Johnson; David J Mooney
Journal:  Adv Mater       Date:  2021-03-24       Impact factor: 30.849

7.  The cardioprotective effect of microemulsion propofol against ischemia and reperfusion injury in isolated rat heart.

Authors:  Min Jung Hur; Heezoo Kim; Dong Kyu Lee; Sang Ho Lim
Journal:  Korean J Anesthesiol       Date:  2012-04-23

8.  Differential effects of commercial-grade and purified poloxamer 188 on renal function.

Authors:  Martin Emanuele; Balu Balasubramaniam
Journal:  Drugs R D       Date:  2014-06

9.  Poloxamer 188 Attenuates Ischemia-Reperfusion-Induced Lung Injury by Maintaining Cell Membrane Integrity and Inhibiting Multiple Signaling Pathways.

Authors:  Shih-En Tang; Wen-I Liao; Hsin-Ping Pao; Chin-Wang Hsu; Shu-Yu Wu; Kun-Lun Huang; Shi-Jye Chu
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

Review 10.  Development and Characterization of Nanoemulsions for Ophthalmic Applications: Role of Cationic Surfactants.

Authors:  Ana R Fernandes; Elena Sanchez-Lopez; Tiago Dos Santos; Maria L Garcia; Amelia M Silva; Eliana B Souto
Journal:  Materials (Basel)       Date:  2021-12-08       Impact factor: 3.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.